Vayra Regrow
Keep the hair you have, physician-led
Physician-prescribed hair-loss treatment for men and women. Choose the FDA-approved brand or Vayra Regrow, our finasteride and minoxidil label, with medication priced separately and shown with your total.
Photography is illustrative. Models shown, not actual patients; individual results vary.
Every protocol on this page is directed by a licensed physician and reviewed against current clinical evidence. Vayra is a clinical practice, not a refill form.
Reviewed by Hammad Qureshi, MD, Medical Director.
Meet our cliniciansWhat we treat in this protocol.
Vayra is a medical practice, not a marketplace. Whether a compounded therapy is appropriate, and which one, is a clinical decision made by your physician at the encounter, under documented clinical decision-making and titrated against your labs.
Male-pattern hair loss
Finasteride, minoxidil, or combination, individualized at the visit
Female-pattern hair loss
Women's dosing available where clinically appropriate
Two paths, priced in the open
Choose the FDA-approved brand or the Vayra value version. Either way, your care membership and medication are two clear line items, shown together with the total before you start.
- Propecia (finasteride)
- Rogaine (minoxidil)
Same active as the brand, at better value. The Vayra option is physician-prescribed and individualized at your visit. Vayra name pending trademark clearance.
What you can expect.
Every Vayra protocol begins with a video consultation with a licensed clinician and a review of your baseline labs. From there, the protocol is titrated against your response, not against a population average.
Universal intake & baseline labs
8-minute clinical assessment with universal safety screening (PHQ-2, GAD-2, C-SSRS). Baseline lab panel ordered immediately on enrollment, drawn at a contracted lab partner near you.
Physician consultation
Video visit with your prescribing physician within 24 to 48 hours of intake completion. Lab review, protocol design, prescription routing through your Patient Dashboard.
Titration and follow-up labs
Every protocol titrates over 4-12 weeks based on tolerability and labs. Follow-up lab panel at week 6-8, then quarterly. Async messaging with your physician anytime.
Cross-vertical coordination
Your Unified Patient Record makes coordination structural. Mandatory drug-interaction screening before every prescription change, across every vertical.
Vayra Restore
Personalized peptide protocols, prescribed by a Vayra-affiliated physician when clinically appropriate and titrated against your labs. The specific compound, dose, and titration are determined at the encounter, never from a marketplace menu. Medication is priced at your visit and shown with your total.
Priced in the open. No surprise bills.
Your membership covers physician care and labs; medication is priced per program and shown with the total. No insurance forms, no itemized surprises. You know what you pay before you start.
Begin with a clinical encounter, not a checkout.
Your assessment takes eight minutes. A licensed provider reviews it within 24 to 48 hours. No charge to begin.
Begin assessmentWegovy® and Saxenda® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. Vayra is not affiliated with or endorsed by Novo Nordisk or Eli Lilly. All third-party trademarks are the property of their respective owners.